These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9017256)

  • 1. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons.
    Cheng N; Maeda T; Kume T; Kaneko S; Kochiyama H; Akaike A; Goshima Y; Misu Y
    Brain Res; 1996 Dec; 743(1-2):278-83. PubMed ID: 9017256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-DOPA neurotoxicity is mediated by glutamate release in cultured rat striatal neurons.
    Maeda T; Cheng N; Kume T; Kaneko S; Kouchiyama H; Akaike A; Ueda M; Satoh M; Goshima Y; Misu Y
    Brain Res; 1997 Oct; 771(1):159-62. PubMed ID: 9383020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.
    Alexander T; Sortwell CE; Sladek CD; Roth RH; Steece-Collier K
    Cell Transplant; 1997; 6(3):309-15. PubMed ID: 9171163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.
    Pedrosa R; Soares-da-Silva P
    Br J Pharmacol; 2002 Dec; 137(8):1305-13. PubMed ID: 12466240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
    Nakao N; Nakai K; Itakura T
    Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-culture with the striatum attenuates N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of rat mesencephalic slice cultures.
    Maeda T; Ibi M; Shimazu S; Akaike A
    Jpn J Pharmacol; 1998 Jun; 77(2):161-7. PubMed ID: 9681573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
    Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
    El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
    Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
    Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
    Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adeno-associated virus-mediated gene transfer of human aromatic L-amino acid decarboxylase protects mixed striatal primary cultures from L-DOPA toxicity.
    Doroudchi MM; Liauw J; Heaton K; Zhen Z; Forsayeth JR
    J Neurochem; 2005 May; 93(3):634-40. PubMed ID: 15836622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity.
    Takeshima M; Murata M; Urasoe N; Murakami S; Miyazaki I; Asanuma M; Kita T
    Neurol Res; 2011 Dec; 33(10):1050-6. PubMed ID: 22196758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
    Paolone G; Brugnoli A; Arcuri L; Mercatelli D; Morari M
    Mov Disord; 2015 Nov; 30(13):1728-38. PubMed ID: 26207892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
    Rocchitta G; Migheli R; Esposito G; Marchetti B; Desole MS; Miele E; Serra PA
    J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-DOPA administration enhances 6-hydroxydopamine generation.
    Maharaj H; Sukhdev Maharaj D; Scheepers M; Mokokong R; Daya S
    Brain Res; 2005 Nov; 1063(2):180-6. PubMed ID: 16257392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha(2) adrenoceptor antagonist idazoxan alleviates L-DOPA-induced dyskinesia by reduction of striatal dopamine levels: an in vivo microdialysis study in 6-hydroxydopamine-lesioned rats.
    Buck K; Voehringer P; Ferger B
    J Neurochem; 2010 Jan; 112(2):444-52. PubMed ID: 19895663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2002 Feb; 926(1-2):149-55. PubMed ID: 11814417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.